Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
31.42
+1.30 (4.32%)
At close: Nov 4, 2026, 4:00 PM EST
31.65
+0.23 (0.73%)
After-hours: Nov 4, 2026, 4:10 PM EST
Surrozen Market Cap
Surrozen has a market cap or net worth of $549.7 million as of November 4, 2026. It is the 13,851st most valuable company in the world and the 2,692nd biggest in the United States. Its market cap has increased by 391.11% in one year.
Market Cap
549.70M
Enterprise Value
453.98M
1-Year Change
391.11%
Global Rank
Country Rank
#2,692 United States
Category
ChartMarket Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $549.70M, an increase of 355.60%. That is a compound annual growth rate of 29.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 549.70M | 160.90% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 525.25M |
| Valneva SE | 505.14M |
| Faeth Therapeutics | 492.52M |
| MiMedx Group | 491.77M |
| Arvinas | 489.74M |
| DiaMedica Therapeutics | 485.87M |
| Oculis Holding AG | 480.28M |
| Gyre Therapeutics | 472.91M |